Iron Formulations and Allergic Reactions
Comparison of IV Iron Formulations
- Iron sucrose is the iron formulation least likely to cause allergic reactions, with very few serious adverse events reported even in pediatric populations 1
- Iron dextran has the highest risk of allergic reactions among IV iron preparations, with anaphylaxis-like reactions occurring in fewer than 1% of administrations 2
- Low molecular weight iron dextran has fewer adverse effects than high molecular weight dextran 1
- Iron gluconate has a lower risk of allergic reactions than iron dextran, with no fatalities reported in association with its use 2
- Test dose recommended for iron gluconate, but reactions to test doses have limited predictive value 3
Oral Iron Formulations
- Oral iron formulations generally have a lower risk of serious allergic reactions compared to IV formulations 6
- Available oral iron options include ferrous sulfate, ferrous gluconate, ferrous fumarate, polysaccharide-iron complex, and ferrous bisglycinate, with rates of mild reactions approximately 1:200 and rates of major reactions approximately 1:200,000 6
Clinical Recommendations
- For patients with a history of multiple drug allergies, iron sucrose is the safest option, and iron dextran should be avoided 3, 1
- All IV iron should be administered by personnel trained to provide emergency treatment, with immediate access to medications needed for treating serious allergic reactions 2
- When using IV iron, patients should be monitored for at least 15-60 minutes after administration, and emergency medications such as epinephrine, corticosteroids should be readily available 2, 3
- For mild infusion reactions, stopping the infusion and restarting 15 minutes later at a slower rate may be sufficient, while corticosteroids may be beneficial for more severe reactions 5
Special Considerations
- True allergy to IV iron is very rare, with most reactions being complement activation-related pseudo-allergy 5
- Test doses have limited value in predicting severe reactions to subsequent doses, and an uneventful response to one iron preparation does not preclude an adverse reaction to another or to repeat administration of the same agent 2, 3